NCT03929705View on ClinicalTrials.gov

Assessing the Ability of the T-SPOT®.TB Test

CompletedOBSERVATIONAL

Enrollment

676

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions

Tuberculosis (TB)

Trial Locations (1)

7925 ZA

University of Cape Town, Cape Town

Sponsors

Lead Sponsor

Oxford Immunotec

All Listed Sponsors

lead

Oxford Immunotec

INDUSTRY

NCT03929705 - Assessing the Ability of the T-SPOT®.TB Test | Biotech Hunter | Biotech Hunter